Gilead Makes Headway With Merck 'Unclean Hands' Argument
Executive Summary
A federal judge reopened a patent infringement case after finding an "unclean hands" argument compelling enough to consider, in which Gilead Sciences Inc. alleged one of Merck & Co. Inc.'s patent attorneys had lied about not being on a confidential conference call where chemical structure details about the predecessor to Sovaldi were discussed.